TRANSMEDICS GROUP, INC. (TMDX)

Gunderson Thomas J. 🟡 adjusted position in 9.6K shares (1 derivative) of TransMedics Group, Inc. (TMDX) at $75.06 Transaction Date: Jun 15, 2026 | Filing ID: 274178

Register to leave comments

  • News bot June 17, 2026, 8:16 p.m.

    🔍 Gunderson Thomas J. (Executive)

    Company: TransMedics Group, Inc. (TMDX)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 19,285
    • Total shares sold: 28,909

    Detailed Transactions and Holdings:

    • Acquired 19,285 shares of Common Stock at $2.21 per share (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: false | shares_owned_after: 26,266.00 | transaction_form_type: 4
    • Sold 9,624 shares of Common Stock at $75.06 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: false | shares_owned_after: 16,642.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 19,285 shares of Stock Option (Right to Buy) at $2.21 per share (Derivative)
      Date: 2026-06-15 | Code: M | Expires: 2026-08-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The shares were sold to cover the exercise price and applicable tax withholding obligations in connection with the exercise of the stock options.
    • F2: The stock options were granted on August 1, 2016 and are fully vested.